Targeting Cell Cycle Protein in Gastric Cancer With CDC20siRNA and Anticancer Drugs (Doxorubicin and Quercetin) Co-Loaded Cationic PEGylated Nanoniosomes

International Journal of Nanomedicine - New Zealand
doi 10.2147/ijn.s211844
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Lung Cancer Combination Therapy: Doxorubicin and Β-Elemene Co-Loaded, pH-sensitive Nanostructured Lipid Carriers

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2019English

Codelivery of Doxorubicin and JIP1 siRNA With Novel EphA2-targeted PEGylated Cationic Nanoliposomes to Overcome Osteosarcoma Multidrug Resistance

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

Efficient Intravesical Therapy of Bladder Cancer With Cationic Doxorubicin Nanoassemblies

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2016English

An Insight Into Cancer and Anticancer Drugs

Acta Scientific Medical Sciences
2019English

Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin

Clinical Medicine Reviews in Women's Health
2010English

Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy

OnCOReview
Oncology
2017English

574. Combination Anticancer Therapy of Doxorubicin and siRNA by Acid-Labile Polymer-Based Cationic Liposomes

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Rnf2 Knockdown Reduces Cell Viability and Promotes Cell Cycle Arrest in Gastric Cancer Cells

Oncology Letters
Cancer ResearchOncology
2017English

Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy